Rovaldi Christopher

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2025-09-12	2025-09-12	Keros Therapeutics Inc (KROS)	PrS Proposed sale	14,198 450.26 US$934,487	14,198	450.26	US$934,487
2022-04-08	2022-04-06	Keros Therapeutics Inc (KROS)	PlS Planned sale	62,869 -24.6% 322.50 US$1,505,364	62,869 -24.6%	322.50	US$1,505,364
2022-04-05	2022-04-01	Keros Therapeutics Inc (KROS)	PlS Planned sale	19,981 -9.6% 495.38 US$465,888	19,981 -9.6%	495.38	US$465,888
2022-04-05	2022-04-01	Keros Therapeutics Inc (KROS)	PlS Planned sale	366 -77.7% 57.97 US$21,217	366 -77.7%	57.97	US$21,217
2022-04-05	2022-04-01	Keros Therapeutics Inc (KROS)	PlS Planned sale	287 -37.9% 56.89 US$16,327	287 -37.9%	56.89	US$16,327
2022-04-05	2022-04-01	Keros Therapeutics Inc (KROS)	PlS Planned sale	104 -12.1% 56.20 US$5,845	104 -12.1%	56.20	US$5,845
2022-04-05	2022-04-01	Keros Therapeutics Inc (KROS)	PlS Planned sale	2 -0.2% 54.34 US$109	2 -0.2%	54.34	US$109